Compared with previous studies that have looked at changes in post-stroke IGF-I, the number of patients in the Sahlgrenska Academy Study on Ischemic Stroke (SAHLSIS) cohort is relatively high [11]. The gene discussed is IGF1; the disease is stroke disorder.